NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied	Psoriasis
Date of first enrollment	15/06/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : LY3009104 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : 1, 2, 4, 8mg or placebo

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	[1] Are >=18 years of age. [2] Have had chronic plaque Ps (based on the disease diagnostic criteria for Ps vulgaris) for at least 6 months prior to entry. [3] Are candidates for systemic therapy and/or phototherapy. [4] Have involvement of at least 12% of their body surface area (BSA) at the time of entry. [5] Have a PASI score of at least 12 at the time of entry. [6] Have an sPGA score of at least 3 at the time of entry. [7] Are willing and able to give written informed consent.
Exclude criteria